Here are some of the key issues we face as a company:
We are working to improve access to our medicines worldwide. Despite the fact that in some countries healthcare issues are incredibly complex, Pfizer realises it has a role to play, and we’re committed to working in partnership with other national and international public health agencies.
We all look forward to a time when using animals in research is no longer necessary. But there is currently no alternative if we want to find cures for AIDS and other infectious diseases, heart disease, stroke and cancer. Techniques such as tissue studies and computer models have greatly reduced the number of animals required to determine the efficacy and safety of medicines.
Patient safety is the number one priority in our clinical studies. Wherever they take place, our trials are conducted within strict international guidelines laid down by the Declaration of Helsinki. They are also conducted in accordance with local laws and regulations and other recognised standards.